Veristat · 1 day ago
Principal Biostatistician
Veristat is a global team with over 30 years of expertise in accelerating life-changing therapies to patients worldwide. The Principal Biostatistician provides statistical input into Phase I - IV clinical trial development, analyzes clinical trial data, and serves as a lead statistician on clinical trials.
Responsibilities
Provides statistical input into Phase I - IV clinical trial development
Performs the analysis of clinical trial data
Provides statistical input into the reporting of clinical trial results
Can work independently and function as a lead statistician on clinical trials
Qualification
Required
PhD degree in Statistics, Biostatistics, or related field, and 5 years of biostatistical experience in the clinical trials or health research environment OR a Master's degree in Statistics, Biostatistics, or related field, and 8 years of biostatistical experience in the clinical trials or health research environment
Excellent written and oral communication skills including grammatical/technical writing skills and familiarity with moderately complex statistical methods that apply to Phase IIV clinical trials are required
Familiarity with SAS, SPSS or other statistical software package
Proficiency in Microsoft Word and Excel
Strong level of detail orientation
Ability to work on multiple tasks under tight timelines
Benefits
Remote working
Flexible time off
Paid holidays
Medical insurance
Tuition reimbursement
Retirement plans
Company
Veristat
Veristat is a full service Clinical Research Organization (CRO).
H1B Sponsorship
Veristat has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (1)
2023 (2)
2022 (5)
2021 (2)
2020 (11)
Funding
Current Stage
Late StageTotal Funding
unknownKey Investors
WindRose Health Investors
2021-04-07Private Equity
Leadership Team
Recent News
2026-01-14
Company data provided by crunchbase